Yuanmei Biological (603983.SH) plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange.

The Zhitong Finance APP news, Wanmei Biology (603983.SH) announced that, in order to enhance the company's capital strength and overseas financing capabilities, further improve the company's overall competitiveness, and accelerate the internationalization strategy of the company's business, in accordance with the company's overall development strategy and operational needs, the company plans to issue H shares and apply for listing on the main board of the Stock Exchange of Hong Kong Limited ("Hong Kong Stock Exchange").